Cooley advised Veritone, DLA Piper advised Insignia Capital Group, and Sheppard Mullin advised Oxford Road on the deal. Oxford Road and Veritone One, two leading audio...
Insignia Capital’s Acquisition of Oxford Road and Veritone One
Roche’s $1.5 Billion Acquisition of Poseida Therapeutics
Sidley Austin represented Roche in the transaction, and Cooley represented Poseida Therapeutics. Roche, one of the world’s largest biotechnology companies and the global leader in in-vitro...
Kura Oncology’s Collaboration with Kyowa Kirin
Wilson Sonsini Goodrich & Rosati and Cooley advised Kura Oncology. Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision...
GHO Capital Partners and Ampersand Capital Partners’ $1.1 Billion Acquisition of Avid Bioservices
Ropes & Gray represented GHO Capital Partners and Ampersand Capital Partners in the transaction, and Cooley represented Avid Bioservices, Inc. GHO Capital Partners, LP (“GHO Capital”),...
Tempus AI’s $600 Million Acquisition of Ambry Genetics
Debevoise & Plimpton advised Konica Minolta, Inc. on the transaction, and Cooley advised Tempus AI, Inc. Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the...
Lundbeck’s $2.6 Billion Acquisition of Longboard Pharmaceuticals
Baker McKenzie represented H.Lundbeck A/S (Lundbeck) in the transaction, Cooley represented Longboard Pharmaceuticals and Wilson Sonsini Goodrich & Rosati represented Evercore, Longboard’s financial advisor. H. Lundbeck...
BioAge Labs’ $238 Million Upsized Initial Public Offering
Fenwick & West represented BioAge Labs, Inc. in the offering, and Cooley represented the underwriters. BioAge Labs, Inc. (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...
Ridgeview Partners’ Investment in PayRange
Sidley Austin is advising Ridgeview Partners on the transaction, and Wilson, Sonsini, Goodrich & Rosati is advising PayRange. Ridgeview Partners, a growth-oriented technology private equity firm,...
Vignette Bio’s Merger with Candid Therapeutics
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Vignette Bio in the transaction, and Cooley represented Candid Therapeutics. Candid Therapeutics, a biotechnology company, acquired Vignette Bio...
ArsenalBio’s $325 Million Series C Financing Round
Cooley, Goodwin Procter and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Arsenal Biosciences on the transaction. Arsenal Biosciences (ArsenalBio) announced raising $325 million in Series...
Genstar Capital’s Investment in AffiniPay
Ropes & Gray represented Genstar Capital in the transaction, and Goodwin Procter represented TA Partner. Genstar Capital (“Genstar”) and TA Associates (“TA”) announced that they have...
TSG Consumer Partners’ Investment in Summer Fridays
Ropes & Gray represented TSG Consumer Partners in the transaction, and Cooley represented Summer Fridays. TSG Consumer Partners announced its investment in Summer Fridays, a clean,...